1-8 of 8
Tadaaki Yamada
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells

Soichi Hirai, Tadaaki Yamada, Yuki Katayama, Masaki Ishida, Hayato Kawachi, Yohei Matsui, Ryota Nakamura, Kenji Morimoto, Mano Horinaka, Toshiyuki Sakai, Yoshitaka Sekido, Shinsaku Tokuda, Koichi Takayama
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2024) 23 (2): 212–222.
https://doi.org/10.1158/1535-7163.MCT-23-0138
Published: 01 February 2024
View article titled, Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells
Open the PDF for Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells in another window
Includes: Supplementary data
Journal Articles

Distribution and Activity of Lenvatinib in Brain Tumor Models of Human Anaplastic Thyroid Cancer Cells in Severe Combined Immune Deficient Mice

Rong Wang, Tadaaki Yamada, Sachiko Arai, Koji Fukuda, Hirokazu Taniguchi, Azusa Tanimoto, Akihiro Nishiyama, Shinji Takeuchi, Kaname Yamashita, Koshiro Ohtsubo, Junji Matsui, Naoyoshi Onoda, Eishu Hirata, Shu Taira, Seiji Yano
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (5): 947–956.
https://doi.org/10.1158/1535-7163.MCT-18-0695
Published: 01 May 2019
View article titled, Distribution and Activity of Lenvatinib in Brain Tumor Models of Human Anaplastic Thyroid Cancer Cells in Severe Combined Immune Deficient Mice
Open the PDF for Distribution and Activity of Lenvatinib in Brain Tumor Models of Human Anaplastic Thyroid Cancer Cells in Severe Combined Immune Deficient Mice in another window
Includes: Supplementary data
Journal Articles

Histone Deacetylase Inhibition Enhances the Antitumor Activity of a MEK Inhibitor in Lung Cancer Cells Harboring RAS Mutations

Tadaaki Yamada, Joseph M. Amann, Azusa Tanimoto, Hirokazu Taniguchi, Takehito Shukuya, Cynthia Timmers, Seiji Yano, Konstantin Shilo, David P. Carbone
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1): 17–25.
https://doi.org/10.1158/1535-7163.MCT-17-0146
Published: 01 January 2018
View article titled, Histone Deacetylase Inhibition Enhances the Antitumor Activity of a MEK Inhibitor in Lung Cancer Cells Harboring <em>RAS</em> Mutations
Open the PDF for Histone Deacetylase Inhibition Enhances the Antitumor Activity of a MEK Inhibitor in Lung Cancer Cells Harboring <em>RAS</em> Mutations in another window
Includes: Supplementary data
Journal Articles

MET Copy Number Gain Is Associated with Gefitinib Resistance in Leptomeningeal Carcinomatosis of EGFR-mutant Lung Cancer

Shigeki Nanjo, Sachiko Arai, Wei Wang, Shinji Takeuchi, Tadaaki Yamada, Akito Hata, Nobuyuki Katakami, Yasunori Okada, Seiji Yano
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (3): 506–515.
https://doi.org/10.1158/1535-7163.MCT-16-0522
Published: 02 March 2017
View article titled, <em>MET</em> Copy Number Gain Is Associated with Gefitinib Resistance in Leptomeningeal Carcinomatosis of <em>EGFR</em>-mutant Lung Cancer
Open the PDF for <em>MET</em> Copy Number Gain Is Associated with Gefitinib Resistance in Leptomeningeal Carcinomatosis of <em>EGFR</em>-mutant Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Combined Therapy with Mutant-Selective EGFR Inhibitor and Met Kinase Inhibitor for Overcoming Erlotinib Resistance in EGFR-Mutant Lung Cancer

Takayuki Nakagawa, Shinji Takeuchi, Tadaaki Yamada, Shigeki Nanjo, Daisuke Ishikawa, Takako Sano, Kenji Kita, Takahiro Nakamura, Kunio Matsumoto, Kenichi Suda, Tetsuya Mitsudomi, Yoshitaka Sekido, Toshimitsu Uenaka, Seiji Yano
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (10): 2149–2157.
https://doi.org/10.1158/1535-7163.MCT-12-0195
Published: 09 October 2012
View article titled, Combined Therapy with Mutant-Selective EGFR Inhibitor and Met Kinase Inhibitor for Overcoming Erlotinib Resistance in <em>EGFR</em>-Mutant Lung Cancer
Open the PDF for Combined Therapy with Mutant-Selective EGFR Inhibitor and Met Kinase Inhibitor for Overcoming Erlotinib Resistance in <em>EGFR</em>-Mutant Lung Cancer in another window
Includes: Supplementary data
Journal Articles

E7080 Suppresses Hematogenous Multiple Organ Metastases of Lung Cancer Cells with Nonmutated Epidermal Growth Factor Receptor

Hirokazu Ogino, Masaki Hanibuchi, Soji Kakiuchi, Van The Trung, Hisatsugu Goto, Kenji Ikuta, Tadaaki Yamada, Hisanori Uehara, Akihiko Tsuruoka, Toshimitsu Uenaka, Wei Wang, Qi Li, Shinji Takeuchi, Seiji Yano, Yasuhiko Nishioka, Saburo Sone
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (7): 1218–1228.
https://doi.org/10.1158/1535-7163.MCT-10-0707
Published: 06 July 2011
View article titled, E7080 Suppresses Hematogenous Multiple Organ Metastases of Lung Cancer Cells with Nonmutated Epidermal Growth Factor Receptor
Open the PDF for E7080 Suppresses Hematogenous Multiple Organ Metastases of Lung Cancer Cells with Nonmutated Epidermal Growth Factor Receptor in another window
Includes: Supplementary data
Journal Articles

Abstract A178: Role of tumor and host‐derived HGF in drug resistance to EGFR inhibitors in EGFR activating mutation‐positive lung cancer

Soji Kakiuchi, Seiji Yano, Wei Wang, Qi Li, Tadaaki Yamada, Kunio Matsumoto, Masaki Hanibuchi, Tetsuya Mitsudomi, Yasushi Yatabe, Takuya Kuramoto, Koji Otsuka, Yasuhiko Nishioka, Saburo Sone
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): A178.
https://doi.org/10.1158/1535-7163.TARG-09-A178
Published: 10 December 2009
View article titled, Abstract A178: Role of tumor and host‐derived HGF in drug resistance to EGFR inhibitors in EGFR activating mutation‐positive lung cancer
Journal Articles

Intensification therapy with anti-parathyroid hormone-related protein antibody plus zoledronic acid for bone metastases of small cell lung cancer cells in severe combined immunodeficient mice

Tadaaki Yamada, Hiroaki Muguruma, Seiji Yano, Kenji Ikuta, Hirokazu Ogino, Soji Kakiuchi, Masaki Hanibuchi, Hisanori Uehara, Yasuhiko Nishioka, Saburo Sone
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (1): 119–126.
https://doi.org/10.1158/1535-7163.MCT-08-0874
Published: 12 January 2009
View article titled, Intensification therapy with anti-parathyroid hormone-related protein antibody plus zoledronic acid for bone metastases of small cell lung cancer cells in severe combined immunodeficient mice
Open the PDF for Intensification therapy with anti-parathyroid hormone-related protein antibody plus zoledronic acid for bone metastases of small cell lung cancer cells in severe combined immunodeficient mice in another window